Z-1917-2015 Class II Ongoing

Recalled by HeartWare Inc — Miami Lakes, FL

FDA device recall Z-1917-2015 was initiated by HeartWare Inc on Apr 29, 2015 and is designated Class II. Reason for recall: Complaints with the HVAD Abnormal Power Source Switching. The recall status is ongoing. Affected quantity: 3,747 currently in use.

Recall Details

Product Type
Devices
Report Date
Jul 8, 2015
Initiation Date
Apr 29, 2015
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
3,747 currently in use.

Product Description

HeartWare Ventricular Assist System (HVAD) For use as a bridge-to-cardiac transplantation in patient who are at risk of death from refractory end-stage left ventricular heart failure.

Reason for Recall

Complaints with the HVAD Abnormal Power Source Switching.

Distribution Pattern

US including AL, AZ, CA, CO, CT, DC, DE, FL, GA, IA, IL, IN, KY, LA, MA, MD, MI, MN, MO, MS, NC, NH, NJ, NY, OH, OR, PA, SC, TN, TX, UT, VA and Internationally to Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, Croatia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Greece, Hong Kong, Hungary, India, Israel, Italy, Japan, Korea, Lebanon, Lithuania, Luxemburg, Malaysia, Netherlands, New Zealand, Norway, Poland, Romania, Singapore, Slovakia, South Africa, Spain, Sweden, Switzerland, Turkey, and UK.

Code Information

Catalog #'s US: 1101 and 1103 / OUS: 1100,1101,1102,1104,1104JP and 1205. Serial #: ALL HeartWare HVAD systems currently in use.

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-1917-2015
openFDA file date
Oct 26, 2026
Loaded by RegDataLab
Oct 27, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.